ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.

Moore CL, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo CM, Barlow-Mosha LN, Cressey TR, Violari A, Variava E, Cotton MF, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Saϊdi Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger DM, Shakeshaft C, Giaquinto C, Rojo P, Gibb DM, Ford D, ODYSSEY Trial Team

Open source

DOI: 10.1186/s12879-020-05672-6
Published: 2021 Jan 4
Container: BMC infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12879-020-05672-6,
  title = {ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.},
  author = {Moore CL and Turkova A and Mujuru H and Kekitiinwa A and Lugemwa A and Kityo CM and Barlow-Mosha LN and Cressey TR and Violari A and Variava E and Cotton MF and Archary M and Compagnucci A and Puthanakit T and Behuhuma O and Saϊdi Y and Hakim J and Amuge P and Atwine L and Musiime V and Burger DM and Shakeshaft C and Giaquinto C and Rojo P and Gibb DM and Ford D and ODYSSEY Trial Team},
  year = {2021},
  journal = {BMC infectious diseases},
  doi = {10.1186/s12879-020-05672-6},
  url = {https://doi.org/10.1186/s12879-020-05672-6}
}

RIS

TY  - JOUR
TI  - ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
AU  - Moore CL
AU  - Turkova A
AU  - Mujuru H
AU  - Kekitiinwa A
AU  - Lugemwa A
AU  - Kityo CM
AU  - Barlow-Mosha LN
AU  - Cressey TR
AU  - Violari A
AU  - Variava E
AU  - Cotton MF
AU  - Archary M
AU  - Compagnucci A
AU  - Puthanakit T
AU  - Behuhuma O
AU  - Saϊdi Y
AU  - Hakim J
AU  - Amuge P
AU  - Atwine L
AU  - Musiime V
AU  - Burger DM
AU  - Shakeshaft C
AU  - Giaquinto C
AU  - Rojo P
AU  - Gibb DM
AU  - Ford D
AU  - ODYSSEY Trial Team
PY  - 2021
JO  - BMC infectious diseases
DO  - 10.1186/s12879-020-05672-6
UR  - https://doi.org/10.1186/s12879-020-05672-6
ER  -

APA

CL, M., A, T., H, M., A, K., A, L., CM, K., LN, B., TR, C., A, V., E, V., MF, C., M, A., A, C., T, P., O, B., Y, S., J, H., P, A., L, A., V, M., DM, B., C, S., C, G., P, R., DM, G., D, F., & Team, O. T. (2021). ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.. BMC infectious diseases. https://doi.org/10.1186/s12879-020-05672-6

Source records

pubmed · retrieved 2026-09-26T17:38:11.700Z